1. Home
  2. SEER vs HGLB Comparison

SEER vs HGLB Comparison

Compare SEER & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seer Inc.

SEER

Seer Inc.

N/A

Current Price

$1.56

Market Cap

113.0M

Sector

Health Care

ML Signal

N/A

Logo Highland Global Allocation Fund

HGLB

Highland Global Allocation Fund

N/A

Current Price

$4.95

Market Cap

122.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
SEER
HGLB
Founded
2017
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
122.2M
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
SEER
HGLB
Price
$1.56
$4.95
Analyst Decision
Buy
Analyst Count
2
0
Target Price
★ $4.00
N/A
AVG Volume (30 Days)
142.8K
★ 176.9K
Earning Date
11-10-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
★ 9.40
N/A
EPS
N/A
★ N/A
Revenue
★ $16,578,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.50
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 16.99
N/A
52 Week Low
$1.55
$4.75
52 Week High
$2.38
$10.11

Technical Indicators

Market Signals
Indicator
SEER
HGLB
Relative Strength Index (RSI) 27.98 13.55
Support Level N/A N/A
Resistance Level $1.85 $7.67
Average True Range (ATR) 0.12 0.27
MACD -0.02 -0.10
Stochastic Oscillator 5.45 11.32

Price Performance

Historical Comparison
SEER
HGLB

About SEER Seer Inc.

Seer Inc is a life sciences company, develops and commercializes products to decode the biology of the proteome. The company offers Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company operates in China, Australia, Eastern Europe, Israel, Japan and South Africa.

About HGLB Highland Global Allocation Fund

Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.

Share on Social Networks: